Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
International Immunopharmacology|March 11, 2011
Specific effect of immunomodulatory quinoline-3-carboxamide ABR-215757 in GM-CSF stimulated bone marrow cell cultures: block of initiation of proliferation of Gr-1+ cellsSofia Helmersson, Martin Stenström, Tomas Leanderson, et al.
Biochemical and Biophysical Research Communications|April 22, 2018
Induction of S100A9 homodimer formation in vivoEva Källberg, Sahar Tahvili, Fredrik Ivars, et al.
BMC Cancer|July 13, 2016
The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b(+) Ly6C(hi) cells to tumor tissue reduces tumor growthAdnan Deronic, Sahar Tahvili, Tomas Leanderson, et al.
Biochemical and Biophysical Research Communications|May 2, 2006
SPI-C and STAT6 can cooperate to stimulate IgE germline transcriptionRobert Carlsson, Kaisa Thorell, David Liberg, et al.
Journal of Neuroimmunology|February 14, 2006
Inhibition of the development of chronic experimental autoimmune encephalomyelitis by laquinimod (ABR-215062) in IFN-beta k.o. and wild type miceAnna Runström, Tomas Leanderson, Lennart Ohlsson, et al.
European Journal of Immunology|December 26, 2001
Ly6C expression differentiates plasma cells from other B cell subsets in miceJens Wrammert, Eva Källberg, William W Agace, et al.
The Prostate|August 6, 2010
Indoleamine 2,3-dioxygenase (IDO) activity influence tumor growth in the TRAMP prostate cancer modelEva Källberg, Pernilla Wikström, Anders Bergh, et al.
Plos One|April 30, 2013
Human S100A9 protein is stabilized by inflammatory stimuli via the formation of proteolytically-resistant homodimersMatteo Riva, Zhifei He, Eva Källberg, et al.
Plos One|May 10, 2018
Paquinimod prevents development of diabetes in the non-obese diabetic (NOD) mouseSahar Tahvili, Marie Törngren, Dan Holmberg, et al.
The American Journal of Pathology|March 20, 2013
Amelioration of experimental autoimmune encephalomyelitis by the quinoline-3-carboxamide paquinimod: reduced priming of proinflammatory effector CD4(+) T cellsSofia Helmersson, Anette Sundstedt, Adnan Deronic, et al.
Pageof 7